{"id":"abcd","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Without access to detailed clinical trial data or published literature on this specific investigational compound, the precise molecular mechanism cannot be reliably determined. Phase 3 status indicates it has progressed through earlier safety and efficacy testing, but the mechanism remains proprietary or undisclosed.","oneSentence":"ABCD is an investigational drug in phase 3 development by CSPC Ouyi Pharmaceutical Co., Ltd., but its specific mechanism of action is not publicly disclosed.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:58:31.161Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05452278","phase":"NA","title":"A Relative Bioavailability Study of Nicotine Delivery From Selected Oral Nicotine Products","status":"COMPLETED","sponsor":"Imperial Brands PLC","startDate":"2021-10-21","conditions":"Healthy Volunteers","enrollment":27},{"nctId":"NCT06588595","phase":"PHASE4","title":"The Switching Antiplatelet-9 (SWAP-9) Study","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-11-01","conditions":"Coronary Arterial Disease (CAD)","enrollment":90},{"nctId":"NCT05332262","phase":"","title":"A Precision Medicine Approach to Identify Patients Undergoing Elective PCI at Risk of Peri-PCI Myocardial Infarction","status":"RECRUITING","sponsor":"University of Florida","startDate":"2022-05-23","conditions":"Coronary Artery Disease","enrollment":500},{"nctId":"NCT07116161","phase":"NA","title":"Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore","status":"RECRUITING","sponsor":"National Cancer Centre, Singapore","startDate":"2025-07-14","conditions":"Fatigue, Breast Cancer Female","enrollment":100},{"nctId":"NCT07338708","phase":"NA","title":"Visual Outcomes and Quality of Life After Vivity EDOF IOL Implantation in Early-Stage Keratoconus","status":"COMPLETED","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2024-09-17","conditions":"Cataract, Keratoconic Subjects","enrollment":10},{"nctId":"NCT06834113","phase":"NA","title":"Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset","status":"RECRUITING","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2025-01-24","conditions":"HIV I Infection, Injection Pain","enrollment":120},{"nctId":"NCT07214922","phase":"PHASE1","title":"Relative Bioavailability of Evobrutinib Tablet Batches","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2023-01-18","conditions":"Healthy","enrollment":28},{"nctId":"NCT06715670","phase":"PHASE1","title":"A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-12-05","conditions":"Liver Cirrhosis","enrollment":30},{"nctId":"NCT07239765","phase":"PHASE3","title":"A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD","status":"COMPLETED","sponsor":"CSPC Ouyi Pharmaceutical Co., Ltd.","startDate":"2021-07-09","conditions":"Invasive Mold Disease","enrollment":67},{"nctId":"NCT07025148","phase":"PHASE4","title":"Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-10-01","conditions":"Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)","enrollment":40},{"nctId":"NCT07220954","phase":"PHASE1","title":"A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2025-11-10","conditions":"Healthy Participants","enrollment":21},{"nctId":"NCT07194538","phase":"","title":"One-Year Outcomes After Conventional vs Accelerated Epi-Off Corneal Cross-Linking in Progressive Keratoconus (Observational Cohort)","status":"COMPLETED","sponsor":"Clinical Hospital Centre Zagreb","startDate":"2021-05-09","conditions":"Keratoconus","enrollment":20},{"nctId":"NCT05468164","phase":"PHASE1","title":"A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-05-31","conditions":"Healthy","enrollment":20},{"nctId":"NCT05630274","phase":"PHASE1","title":"A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2019-04-16","conditions":"Healthy","enrollment":32},{"nctId":"NCT04483583","phase":"PHASE4","title":"Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-12-08","conditions":"Coronary Artery Disease","enrollment":81},{"nctId":"NCT06369623","phase":"NA","title":"Monetary Incentive Delay Task for Probing Reward-related Neural Processes","status":"RECRUITING","sponsor":"Stony Brook University","startDate":"2024-04-06","conditions":"Adolescent Development","enrollment":300},{"nctId":"NCT06633276","phase":"","title":"Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)","status":"RECRUITING","sponsor":"University of Bonn","startDate":"2025-05","conditions":"Breast Cancer Invasive","enrollment":100},{"nctId":"NCT04451187","phase":"PHASE1","title":"A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-07-16","conditions":"Depressive Disorder, Major","enrollment":63},{"nctId":"NCT06194032","phase":"PHASE1","title":"A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-02-29","conditions":"Healthy Participants","enrollment":28},{"nctId":"NCT02283788","phase":"PHASE1","title":"Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2007-03","conditions":"Epilepsy","enrollment":67},{"nctId":"NCT05450016","phase":"","title":"Assessment of the Breast Cosmesis Using Deep Neural Networks: an Exploratory Study (ABCD)","status":"RECRUITING","sponsor":"Tata Memorial Centre","startDate":"2021-10-04","conditions":"Breast Cancer","enrollment":720},{"nctId":"NCT05707832","phase":"PHASE3","title":"A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus","status":"COMPLETED","sponsor":"CSPC Ouyi Pharmaceutical Co., Ltd.","startDate":"2023-03-30","conditions":"Invasive Candidiasis, Invasive Aspergillosis","enrollment":31},{"nctId":"NCT06346574","phase":"NA","title":"HEART at Head Start Pilot (Healthy Eating, Activity, Relaxation Trial)","status":"COMPLETED","sponsor":"Tufts University","startDate":"2023-12-14","conditions":"Dietary Habits, Physical Inactivity, Sleep Hygiene","enrollment":48},{"nctId":"NCT05459857","phase":"NA","title":"A Randomised, Cross-Over, Nicotine Pharmacokinetic and Pharmacodynamic Study of Heated Tobacco Products Compared to Combustible Cigarettes","status":"COMPLETED","sponsor":"Imperial Brands PLC","startDate":"2021-10-01","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT03923101","phase":"","title":"The Homburg Keratoconus Center (HKC)","status":"RECRUITING","sponsor":"Universität des Saarlandes","startDate":"2011-01-01","conditions":"Keratoconus","enrollment":5000},{"nctId":"NCT03960489","phase":"PHASE1","title":"A Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet Formulation and Pediatric Azo Dye-free Mini-tablet Formulation Compared to a Single Dose of Azo Dye-containing Tablet Formulation in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2019-07-31","conditions":"Healthy Adult Subjects","enrollment":24},{"nctId":"NCT05385406","phase":"NA","title":"HPV Screening With Triage by HPV Genotyping Versus Visual Inspection With Acetic Acid","status":"RECRUITING","sponsor":"Prof. Patrick Petignat","startDate":"2022-12-06","conditions":"Cervical Cancer","enrollment":5500},{"nctId":"NCT06376201","phase":"PHASE4","title":"A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2024-04","conditions":"Invasive Fungal Disease","enrollment":125},{"nctId":"NCT01896505","phase":"PHASE1","title":"A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma","status":"COMPLETED","sponsor":"Karyopharm Therapeutics Inc","startDate":"2013-07-30","conditions":"Sarcoma","enrollment":54},{"nctId":"NCT05422820","phase":"","title":"The Argentina Brief Colonoscopy Difficulty Score (ABCD)","status":"COMPLETED","sponsor":"Institute of Gastroenterology and Advance Endoscopy","startDate":"2022-07-01","conditions":"Colorectal Cancer, Diagnoses Disease, Polyp of Colon","enrollment":5000},{"nctId":"NCT05408780","phase":"PHASE1","title":"A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects","status":"COMPLETED","sponsor":"Cerecin","startDate":"2022-07-14","conditions":"Alzheimer Disease","enrollment":45},{"nctId":"NCT06007105","phase":"NA","title":"SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2023-07-18","conditions":"Schizophrenia, Schizoaffective Disorder, Schizotypal Disorder","enrollment":40},{"nctId":"NCT05505097","phase":"PHASE1","title":"Safety and Pharmacokinetics of Dioxidin, Solution for Topical and External Use, 0.25 mg/ml and Dioxidin, Solution for Infusion and External Use, 5 mg/ml in Healthy Volunteers","status":"COMPLETED","sponsor":"Valenta Pharm JSC","startDate":"2022-05-04","conditions":"Infections","enrollment":16},{"nctId":"NCT05988021","phase":"PHASE1","title":"A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168","status":"COMPLETED","sponsor":"Amgen","startDate":"2015-12-03","conditions":"Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis","enrollment":16},{"nctId":"NCT05963594","phase":"NA","title":"To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2023-01-23","conditions":"Dietary Supplement","enrollment":44},{"nctId":"NCT00187291","phase":"PHASE3","title":"Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study)","status":"COMPLETED","sponsor":"Abbott Medical Devices","startDate":"2001-04","conditions":"Ischemic Cardiomyopathy, LV Dysfunction","enrollment":618},{"nctId":"NCT05355935","phase":"PHASE1","title":"A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2022-04-27","conditions":"Healthy Volunteer","enrollment":48},{"nctId":"NCT05116059","phase":"","title":"To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2021-10-22","conditions":"Invasive Fungal Disease","enrollment":500},{"nctId":"NCT05471063","phase":"NA","title":"Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2022-08-22","conditions":"Cryptococcal Meningitis","enrollment":30},{"nctId":"NCT04094363","phase":"NA","title":"CSD190202: Study to Assess Elements of Abuse Liability for Two Electronic Nicotine Delivery Systems","status":"COMPLETED","sponsor":"RAI Services Company","startDate":"2019-10-03","conditions":"Smoking, Tobacco Smoking, Tobacco Use","enrollment":50},{"nctId":"NCT02395315","phase":"","title":"Alveolar Bone Changes in Diabetes (ABCD) Study","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2015-12","conditions":"Diabetes Mellitus","enrollment":42},{"nctId":"NCT04423744","phase":"PHASE1","title":"Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants","status":"COMPLETED","sponsor":"Bayer","startDate":"2020-06-18","conditions":"Cough, Endometriosis, Overactive Bladder","enrollment":42},{"nctId":"NCT05154968","phase":"PHASE1","title":"A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2021-11-24","conditions":"Healthy Participants","enrollment":44},{"nctId":"NCT04069104","phase":"","title":"Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification","status":"COMPLETED","sponsor":"University of Miami","startDate":"2020-11-13","conditions":"Diagnoses Disease","enrollment":1849},{"nctId":"NCT04128787","phase":"PHASE1","title":"A Study to Compare the Relative Bioavailability of Two AG-881 Formulations and Evaluate the Effect of Food and Omeprazole on the Pharmacokinetics of AG-881","status":"COMPLETED","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2019-09-30","conditions":"Healthy Volunteers","enrollment":36},{"nctId":"NCT04867980","phase":"PHASE1","title":"A Study to Evaluate the Effect of ACP-196 on the Heart Rate-corrected QT Interval in Healthy Adult Participants","status":"COMPLETED","sponsor":"Acerta Pharma BV","startDate":"2016-04-01","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT03919084","phase":"NA","title":"THRIVE+ Pharmacy Liaison-Patient Navigation Intervention","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2019-05-28","conditions":"Healthcare Utilization","enrollment":364},{"nctId":"NCT04488016","phase":"PHASE1","title":"A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy Subjects","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-06-24","conditions":"Bioavailability, B-cell Lymphoid Cancer","enrollment":54},{"nctId":"NCT04694430","phase":"","title":"A Multi-center Study to Determine the Prevalence and Influence of Pertussis on COPD Exacerbation in Shenzhen","status":"UNKNOWN","sponsor":"Shenzhen People's Hospital","startDate":"2021-01-01","conditions":"COPD Exacerbation, Pertussis","enrollment":500},{"nctId":"NCT04565678","phase":"PHASE1","title":"A Study to Assess the Relative Bioavailability and Effect of Food on the Coated Granule Formulation of Mitapivat in Healthy Participants","status":"COMPLETED","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2020-09-21","conditions":"Healthy Volunteers","enrollment":32},{"nctId":"NCT03553108","phase":"PHASE1","title":"A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-05-16","conditions":"Malignant Solid Tumor","enrollment":18},{"nctId":"NCT04128293","phase":"PHASE1","title":"A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants","status":"TERMINATED","sponsor":"ViiV Healthcare","startDate":"2019-10-08","conditions":"HIV Infections","enrollment":16},{"nctId":"NCT01587703","phase":"PHASE1","title":"A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-03-28","conditions":"Carcinoma, Midline","enrollment":196},{"nctId":"NCT04225195","phase":"PHASE2","title":"Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis","status":"UNKNOWN","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2020-01","conditions":"Invasive Candidiasis, Invasive Aspergillosis","enrollment":60},{"nctId":"NCT03501277","phase":"PHASE1","title":"A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants","status":"COMPLETED","sponsor":"Takeda","startDate":"2018-05-26","conditions":"Healthy Volunteers","enrollment":72},{"nctId":"NCT03362723","phase":"PHASE1","title":"A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-11-27","conditions":"Solid Tumors","enrollment":48},{"nctId":"NCT00543062","phase":"PHASE1","title":"Staccato Prochlorperazine Thorough QT/QTc","status":"COMPLETED","sponsor":"Alexza Pharmaceuticals, Inc.","startDate":"2007-10","conditions":"Cardiotoxicity","enrollment":48},{"nctId":"NCT02457169","phase":"NA","title":"Addressing Systemic Health Disparities in Early Identification and Treatment of Autism Spectrum Disorder (ASD): ABCD Project","status":"COMPLETED","sponsor":"University of Massachusetts, Boston","startDate":"2014-09","conditions":"Autism Spectrum Disorder","enrollment":31},{"nctId":"NCT02661594","phase":"PHASE1","title":"Thorough QT Study of Intravenous Amisulpride","status":"COMPLETED","sponsor":"Acacia Pharma Ltd","startDate":"2013-11","conditions":"Healthy","enrollment":40},{"nctId":"NCT02652897","phase":"","title":"Hemostasis Alterations in Neurosurgical Patients","status":"UNKNOWN","sponsor":"Santiago R. Leal-Noval","startDate":"2016-05","conditions":"Glioma, Coagulopathy, Acquired Platelet Function Disorder","enrollment":120},{"nctId":"NCT03577509","phase":"PHASE1","title":"Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China","status":"COMPLETED","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2018-07-02","conditions":"Invasive Fungal Disease","enrollment":30},{"nctId":"NCT03619473","phase":"NA","title":"Standard Motorcycle Child Safety Helmet Initiative (MCHI) Program","status":"UNKNOWN","sponsor":"Universiti Putra Malaysia","startDate":"2016-01-01","conditions":"Head Injuries","enrollment":2000},{"nctId":"NCT02045953","phase":"PHASE1","title":"A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-01-29","conditions":"Asthma","enrollment":21},{"nctId":"NCT03443453","phase":"PHASE1","title":"A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers","status":"COMPLETED","sponsor":"Medivir","startDate":"2018-01-19","conditions":"Healthy","enrollment":18},{"nctId":"NCT00583297","phase":"","title":"Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial","status":"COMPLETED","sponsor":"CardioDx","startDate":"2007-01","conditions":"Ventricular Tachycardia, Cardiovascular Diseases, Arrythmia","enrollment":400},{"nctId":"NCT02336594","phase":"PHASE1","title":"RDEA3170 Bioavailability Study","status":"COMPLETED","sponsor":"Ardea Biosciences, Inc.","startDate":"2014-11","conditions":"Gout","enrollment":15},{"nctId":"NCT00728052","phase":"PHASE1","title":"A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-06-09","conditions":"Substance Dependence","enrollment":18},{"nctId":"NCT01802918","phase":"PHASE1","title":"Single Dose Escalation Study of GSK2838232 in Healthy Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-02-18","conditions":"Infection, Human Immunodeficiency Virus","enrollment":17},{"nctId":"NCT02925546","phase":"PHASE1","title":"A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-10","conditions":"Heart Failure, Congestive","enrollment":18},{"nctId":"NCT02449577","phase":"EARLY_PHASE1","title":"Identification of Biomarkers for Acute Intake of Beer and Alcohol and Acute Effects on Plasma and Insulin Response","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2013-05","conditions":"Alcohol Consumption, Insulin Resistance","enrollment":19},{"nctId":"NCT02376608","phase":"PHASE1","title":"Bioavailability of Omega-3 Food Supplement in Healthy Subjects","status":"COMPLETED","sponsor":"Pronova BioPharma","startDate":"2014-08","conditions":"Biological Availability","enrollment":24},{"nctId":"NCT01785433","phase":"PHASE1, PHASE2","title":"To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-01","conditions":"COPD","enrollment":36},{"nctId":"NCT01859845","phase":"NA","title":"Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of Melanoma","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2013-04","conditions":"Melanoma","enrollment":63},{"nctId":"NCT01785927","phase":"PHASE1","title":"The Safety of Tuberculosis Treatments by Oral Inhalation","status":"UNKNOWN","sponsor":"Prince of Songkla University","startDate":"2013-02","conditions":"Healthy","enrollment":40},{"nctId":"NCT01482689","phase":"NA","title":"Bioavailability of Vitamin D in Cod Liver Oil and Multivitamin Tablets in Healthy Subjects in Norway","status":"COMPLETED","sponsor":"University of Oslo","startDate":"2005-02","conditions":"Healthy","enrollment":74}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"EYE PAIN"},{"count":1,"reaction":"OCULAR HYPERAEMIA"},{"count":1,"reaction":"PHOTOPHOBIA"},{"count":1,"reaction":"SWELLING OF EYELID"}],"_approvalHistory":[],"publicationCount":3806,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ABCD","genericName":"ABCD","companyName":"CSPC Ouyi Pharmaceutical Co., Ltd.","companyId":"cspc-ouyi-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}